Clinical trial
Study of ALS Reversals 4: LifeTime Exposures
NCT03706391 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of ALS Reversals 4: LifeTime Exposures
- Lead sponsor
- Duke University
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 26, 2018
- Completion date
- June 1, 2020
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
amyotrophic lateral sclerosis, motor neuron disease, progressive muscular atrophy